Patents by Inventor Roger Tung

Roger Tung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030203905
    Abstract: The present invention relates to inhibitors of p38, a mammalian protein kinase involved cell proliferation, cell death and response to extracellular stimuli. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.
    Type: Application
    Filed: March 25, 2003
    Publication date: October 30, 2003
    Inventors: John Cochran, Roger Tung
  • Publication number: 20030144253
    Abstract: The present invention relates to acyclic and cyclic amine derivatives for treating or preventing neuronal damage associated with neurological diseases. The invention also provides compositions comprising the compounds of the present invention and methods of utilizing those compositions for treating or preventing neuronal damage.
    Type: Application
    Filed: January 30, 2002
    Publication date: July 31, 2003
    Inventors: Michael Mullican, David Lauffer, Roger Tung
  • Patent number: 6552019
    Abstract: The present invention relates to inhibitors of p38, a mammalian protein kinase involved cell proliferation, cell death and response to extracellular stimuli. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.
    Type: Grant
    Filed: June 11, 2002
    Date of Patent: April 22, 2003
    Inventors: John Cochran, Roger Tung
  • Publication number: 20020115716
    Abstract: This invention relates to orally available compositions which deliver an amount of butyrate or a butyrate analogue effective to ameliorate &bgr;-hemoglobinopathies, such as &bgr;-thalassemia and sickle cell anemia, cystic fibrosis, cancer and other diseases which are known to be treatable with butyrate. The invention also relates to methods of treating these diseases with such low dose oral compositions.
    Type: Application
    Filed: September 19, 2001
    Publication date: August 22, 2002
    Inventors: Pravin Chaturvedi, Michael Su, Roger Tung